Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew L Maddess

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Chemical Information and Modeling|May 8, 2014
Modeling a crowdsourced definition of molecular complexityRobert P Sheridan, Nicolas Zorn, Edward C Sherer, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 29, 2021
Characterization of the Onset, Progression, and Reversibility of Morphological Changes in Mouse Lung after Pharmacological Inhibition of Leucine-Rich Kinase 2 Kinase ActivityDianne K Bryce, Chris M Ware, Janice D Woodhouse, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 11, 2009
Total synthesis of rapamycinSteven V Ley, Miles N Tackett, Matthew L Maddess, et al.
ACS Medicinal Chemistry Letters|April 22, 2022
Diminishing GSH-Adduct Formation of Tricyclic Diazepine-based Mutant IDH1 InhibitorsChunhui Huang, Christian Fischer, Michelle R Machacek, et al.
Science Translational Medicine|April 24, 2020
LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficitsMarco A S Baptista, Kalpana Merchant, Ted Barrett, et al.
Journal of Medicinal Chemistry|March 25, 2022
Discovery of MK-1454: A Potent Cyclic Dinucleotide Stimulator of Interferon Genes Agonist for the Treatment of CancerWonsuk Chang, Michael D Altman, Charles A Lesburg, et al.
Journal of Medicinal Chemistry|December 8, 2022
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1<i>H</i>-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's DiseaseDavid A Candito, Vladimir Simov, Anmol Gulati, et al.
Nature|March 17, 2022
A kinase-cGAS cascade to synthesize a therapeutic STING activatorJohn A McIntosh, Zhijian Liu, Brian M Andresen, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Chemical Information and Modeling|May 8, 2014
Modeling a crowdsourced definition of molecular complexityRobert P Sheridan, Nicolas Zorn, Edward C Sherer, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 29, 2021
Characterization of the Onset, Progression, and Reversibility of Morphological Changes in Mouse Lung after Pharmacological Inhibition of Leucine-Rich Kinase 2 Kinase ActivityDianne K Bryce, Chris M Ware, Janice D Woodhouse, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 11, 2009
Total synthesis of rapamycinSteven V Ley, Miles N Tackett, Matthew L Maddess, et al.
ACS Medicinal Chemistry Letters|April 22, 2022
Diminishing GSH-Adduct Formation of Tricyclic Diazepine-based Mutant IDH1 InhibitorsChunhui Huang, Christian Fischer, Michelle R Machacek, et al.
Science Translational Medicine|April 24, 2020
LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficitsMarco A S Baptista, Kalpana Merchant, Ted Barrett, et al.
Journal of Medicinal Chemistry|March 25, 2022
Discovery of MK-1454: A Potent Cyclic Dinucleotide Stimulator of Interferon Genes Agonist for the Treatment of CancerWonsuk Chang, Michael D Altman, Charles A Lesburg, et al.
Journal of Medicinal Chemistry|December 8, 2022
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1<i>H</i>-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's DiseaseDavid A Candito, Vladimir Simov, Anmol Gulati, et al.
Nature|March 17, 2022
A kinase-cGAS cascade to synthesize a therapeutic STING activatorJohn A McIntosh, Zhijian Liu, Brian M Andresen, et al.
Pageof 2